GTS Securities’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.6K Buy
+13,664
New +$46.4K ﹤0.01% 1269
2026
Q1
Sell
-11,123
Closed -$26.1K 1541
2025
Q4
$26.1K Buy
+11,123
New +$30.4K ﹤0.01% 1333
2024
Q3
Sell
-72,998
Closed -$167K 4101
2024
Q2
$89.8K Buy
72,998
+10,428
+17% +$9.36K ﹤0.01% 3637
2024
Q1
$49.7K Buy
+62,570
New +$56.9K ﹤0.01% 3630

Other funds holding CLOV

GTS Securities's CLOV Position: Q2 2026 in Review

GTS Securities opened a new position in Clover Health Investments (CLOV) in Q2 2026: 13,664 shares worth $71.6K. The stake represents ﹤0.01% of the portfolio and ranks #1269 among its holdings. This is a return to the name: GTS Securities previously reported a position in CLOV as recently as Q4 2025.

GTS Securities first reported a position in CLOV in Q1 2024 and has held it in 4 quarters since. The position peaked at $89.8K in Q2 2024. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • GTS Securities held 13,664 shares of Clover Health Investments worth $71.6K as of Q2 2026.
  • Clover Health Investments was a new GTS Securities position in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1269 holding.
  • GTS Securities first reported a position in Clover Health Investments in Q1 2024 and has held it in 4 quarters since.
  • GTS Securities's Clover Health Investments position peaked at $89.8K in Q2 2024.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.